Climb Bio, Inc. (CLYM) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $35.69M | -59.1% |
| 2024 | $87.23M | -6.3% |
| 2023 | $93.11M | +113.6% |
| 2022 | $43.59M | -7.1% |
| 2021 | $46.92M | +129.0% |
| 2020 | $20.49M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $35.69M | -59.1% |
| 2024 | $87.23M | -6.3% |
| 2023 | $93.11M | +113.6% |
| 2022 | $43.59M | -7.1% |
| 2021 | $46.92M | +129.0% |
| 2020 | $20.49M | — |